New real-time PCR assays for detection of inducible and acquired clarithromycin resistance in the mycobacterium abscessus group

Journal of Clinical Microbiology

Volumn 53, Issue 11, 2015, Pages 3430-3437

  Shallom, Shamira J ^a   Moura, Natalia S ^a   Olivier, Kenneth N ^b   Sampaio, Elizabeth P ^c,d   Holland, Steven M ^c   Zelazny, Adrian M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CLARITHROMYCIN; CYTOSINE; GUANINE; RNA 23S; THYMINE; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; METHYLTRANSFERASE;

ALLELE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ERM GENE; GENE IDENTIFICATION; GENE MUTATION; INCUBATION TIME; MELTING POINT; MYCOBACTERIUM ABSCESSUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPERATURE; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; DNA SEQUENCE; DRUG EFFECTS; GENETICS; HUMAN; LUNG DISEASE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; NUCLEOTIDE SEQUENCE; PROCEDURES; SOFT TISSUE INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; CLARITHROMYCIN; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; HUMANS; LUNG DISEASES; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 23S; SEQUENCE ANALYSIS, DNA; SOFT TISSUE INFECTIONS;

EID: 84945200898     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01714-15     Document Type: Article

References (30)

1. Leao SC, Tortoli E, Euzeby JP, Garcia MJ. 2011. Proposal that Myco-bacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus. Int J Syst Evol Microbiol 61: 2311-2313. http://dx.doi.org/10.1099/ijs.0.023770-0.
2. Bryant JM, Grogono DM, Greaves D, Foweraker J, Roddick I, Inns T, Reacher M, Haworth CS, Curran MD, Harris SR, Peacock SJ, Parkhill J, Floto RA. 2013. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet 381:1551-1560. http://dx.doi.org/10.1016/S0140-6736(13)60632-7.
3. Tettelin H, Davidson RM, Agrawal S, Aitken ML, Shallom S, Hasan NA, Strong M, de Moura VC, De Groote MA, Duarte RS, Hine E, Parankush S, Su Q, Daugherty SC, Fraser CM, Brown-Elliott BA, Wallace RJ, Jr, Holland SM, Sampaio EP, Olivier KN, Jackson M, Zelazny AM. 2014. High-level relatedness among Mycobacterium abscessus subsp. massil-iense strains from widely separated outbreaks. Emerg Infect Dis 20:364-371. http://dx.doi.org/10.3201/eid2003.131106.
4. Olivier KN, Weber DJ, Lee JH, Handler A, Tudor G, Molina PL, Tomashefski J, Knowles MR. 2003. Nontuberculous mycobacteria. II. Nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med 167:835-840.
5. Leao SC, Viana-Niero C, Matsumoto CK, Lima KV, Lopes ML, Palaci M, Hadad DJ, Vinhas S, Duarte RS, Lourenco MC, Kipnis A, das Neves ZC, Gabardo BM, Ribeiro MO, Baethgen L, de Assis DB, Madalosso G, Chimara E, Dalcolmo MP. 2010. Epidemic of surgical-site infections by a single clone of rapidly growing mycobacteria in Brazil. Future Microbiol 5:971-980. http://dx.doi.org/10.2217/fmb.10.49.
6. Benwill JL, Wallace RJ, Jr. 2014. Mycobacterium abscessus: challenges in diagnosis and treatment. Curr Opin Infect Dis 27:506-510. http://dx.doi.org/10.1097/QCO.0000000000000104.
7. Brown BA, Wallace RJ, Jr, Onyi GO De Rosas V, Wallace RJ, III. 1992. Activities of four macrolides including clarithromycin against Mycobac-terium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms Antimicrob Agents Chemother 36:180-184.
8. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Jr, Winthrop K. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367-416. http://dx.doi.org/10.1164/rccm.200604-571ST.
9. Nash KA, Brown-Elliott BA, Wallace RJ, Jr. 2009. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother 53:1367-1376. http://dx.doi.org/10.1128/AAC.01275-08.
10. Kim HY, Kim BJ, Kook Y, Yun YJ, Shin JH, Kim BJ, Kook YH. 2010. Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns. Microbiol Immunol 54:347-353. http://dx.doi.org/10.1111/j.1348-0421.2010.00221.x.
11. Bastian S, Veziris N, Roux AL, Brossier F, Gaillard JL, Jarlier V, Cambau E. 2011. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. Antimicrob Agents Chemother 55:775-781. http://dx.doi.org/10.1128/AAC.00861-10.
12. Sander PPT, Meier A. 1997. The role of ribosomal RNAs in macrolide resistance. Mol Microbiol 26:469-480. http://dx.doi.org/10.1046/j.1365-2958.1997.5811946.x.
13. Pfister P, Jenni S, Poehlsgaard J, Thomas A, Douthwaite S, Ban N, Bottger EC. 2004. The structural basis of macrolide-ribosome binding assessed using mutagenesis of 23S rRNA positions 2058 and 2059. J Mol Biol 342:1569-1581. http://dx.doi.org/10.1016/j.jmb.2004.07.095.
14. Pfister P, Corti N, Hobbie S, Bruell C, Zarivach R, Yonath A, Bottger EC. 2005. 23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A¡G. Proc Natl Acad Sci USA 102:5180-5185. http://dx.doi.org/10.1073/pnas.0501598102.
15. Akshay S, Bertea M, Hobbie SN, Oettinghaus B, Shcherbakov D, Bottger EC, Akbergenov R. 2011. Phylogenetic sequence variations in bacterial rRNA affect species-specific susceptibility to drugs targeting protein synthesis. Antimicrob Agents Chemother 55:4096-4102. http://dx.doi.org/10.1128/AAC.01398-10.
16. Maurer FP, Castelberg C, Quiblier C, Bottger EC, Somoskovi A. 2014. Erm(41)-dependent inducible resistance to azithromycin and clarithro-mycin in clinical isolates of Mycobacterium abscessus. J Antimicrob Che-mother 69:1559-1563. http://dx.doi.org/10.1093/jac/dku007.
17. Kim BJ, Yi SY, Shim TS, Do SY, Yu HK, Park YG, Kook YH, Kim BJ. 2012. Discovery of a novel hsp65 genotype within Mycobacterium massil-iense associated with the rough colony morphology. PLoS One 7:e38420. http://dx.doi.org/10.1371/journal.pone.0038420.
18. Blauwendraat C, Dixon GL, Hartley JC, Foweraker J, Harris KA. 2012. The use of a two-gene sequencing approach to accurately distinguish between the species within the Mycobacterium abscessus complex and My-cobacterium chelonae. Eur J Clin Microbiol Infect Dis 31:1847-1853. http://dx.doi.org/10.1007/s10096-011-1510-9.
19. Zelazny AM, Calhoun LB, Li L, Shea YR, Fischer SH. 2005. Identification of Mycobacterium species by secA1 sequences. J Clin Microbiol 43: 1051-1058. http://dx.doi.org/10.1128/JCM.43.3.1051-1058.2005.
20. Sassi M, Ben Kahla I, Drancourt M. 2013. Mycobacterium abscessus multispacer sequence typing. BMC Microbiol 13:3. http://dx.doi.org/10.1186/1471-2180-13-3.
21. Macheras E, Roux AL, Bastian S, Leao SC, Palaci M, Sivadon-Tardy V, Gutierrez C, Richter E, Rusch-Gerdes S, Pfyffer G, Bodmer T, Cambau E, Gaillard JL, Heym B. 2011. Multilocus sequence analysis and rpoB sequencingofMycobacterium abscessus (sensu lato) strains. J Clin Micro-biol 49:491-499. http://dx.doi.org/10.1128/JCM.01274-10.
22. Zelazny AM, Root JM, Shea YR, Colombo RE, Shamputa IC, Stock F, Conlan S, McNulty S, Brown-Elliott BA, Wallace RJ, Jr, Olivier KN, Holland SM, Sampaio EP. 2009. Cohort study of molecular identification and typingof Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. J Clin Microbiol 47:1985-1995. http://dx.doi.org/10.1128/JCM.01688-08.
23. Shallom SJ, Gardina PJ, Myers TG, Sebastian Y, Conville P, Calhoun LB, Tettelin H, Olivier KN, Uzel G, Sampaio EP, Holland SM, Zelazny AM. 2013. New rapid scheme for distinguishing the subspecies of the Mycobacterium abscessus group and identifying Mycobacterium massil-iense isolates with inducible clarithromycin resistance. J Clin Microbiol 51:2943-2949. http://dx.doi.org/10.1128/JCM.01132-13.
24. Williams KJ, Bryant WA, Jenkins VA, Barton GR, Witney AA, Pinney JW, Robertson BD. 2013. Deciphering the response of Mycobacterium smegmatis to nitrogen stress using bipartite active modules. BMC Genomics 14:436. http://dx.doi.org/10.1186/1471-2164-14-436.
25. CLSI. 2011. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard, 2nd ed, p 14. CLSI document M24-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
26. Mushatt DM, Witzig R. 1995. Successful treatment of Mycobacterium ab-scessus infections with multidrug regimens containing clarithromycin. Clin Infect Dis 20:1441-1442. http://dx.doi.org/10.1093/clinids/20.5.1441.
27. Wallace RJ, Jr, Meier A, Brown BA, Zhang Y, Sander P, Onyi GO, Bottger EC. 1996. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimi-crob Agents Chemother 40:1676-1681.
28. Brown-Elliott BA, Vasireddy S, Vasireddy R, Iakhiaeva E, Howard ST, Nash K, Parodi N, Strong A, Gee M, Smith T, Wallace RJ, Jr. 2015. Utility of sequencing the erm(41) gene in isolates of Mycobacterium ab-scessus subsp. abscessus with low and intermediate clarithromycin MICs. J Clin Microbiol 53:1211-1215. http://dx.doi.org/10.1128/JCM.02950-14.
29. Maurer FP, Ruegger V, Ritter C, Bloemberg GV, Bottger EC. 2012. Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Myco-bacterium abscessus in the presence of inducible erm(41). J Antimicrob Che-mother 67:2606-2611. http://dx.doi.org/10.1093/jac/dks279.
30. Lee SH, Yoo HK, Kim SH, Koh WJ, Kim CK, Park YK, Kim HJ. 2014. Detection and assessment of clarithromycin inducible resistant strains among Korean Mycobacterium abscessus clinical strains: PCR methods. J Clin Lab Anal 28:409-414. http://dx.doi.org/10.1002/jcla.21702.